The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Biological hypotheses and biomarkers of bipolar disorder
Open accessAbstract
The most common mood disorders are major depressive disorders and bipolar disorders (BD). The pathophysiology of BD is complex, multifactorial, and not fully understood. Creation of new hypotheses in the field gives impetus for studies and for finding new biomarkers for BD. Conversely, new biomarkers facilitate not only diagnosis of a disorder and monitoring of biological effects of treatment, but also formulation of new hypotheses about the causes and pathophysiology of the BD. BD is characterized by multiple associations between disturbed brain development, neuroplasticity, and chronobiology, caused by: genetic and environmental factors; defects in apoptotic, immune‐inflammatory, neurotransmitter, neurotrophin, and calcium‐signaling pathways; oxidative and nitrosative stress; cellular bioenergetics; and membrane or vesicular transport. Current biological hypotheses of BD are summarized, including related pathophysiological processes and key biomarkers, which have been associated with changes in genetics, systems of neurotransmitter and neurotrophic factors, neuroinflammation, autoimmunity, cytokines, stress axis activity, chronobiology, oxidative stress, and mitochondrial dysfunctions. Here we also discuss the therapeutic hypotheses and mechanisms of the switch between depressive and manic state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The versatility and universality of calcium signalling
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036035 · Cited by 5,701
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Neurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.999 · Cited by 1,848
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683 · cited 1×
“The levels of IL-1β and sIL-2R were significantly increased in euthymic BD.(159)”
BackgroundTransport of brain-derived neurotrophic factor across the blood–brain barrier
Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296 · cited 1×
“In contrast, GDNF and VEGF do not cross the BBB(111); VEGF enhances angiogenesis and promotes BBB leakage in the ischemic brain.(112)”
BackgroundThe role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · cited 1×
“A dopamine hypothesis of BD was formulated that suggests a role of increased dopaminergic transmission in mania and the converse in depression.(49,50) The hypothesis is supported by the fact that altered availability of dopamine transporter has been accepted as a biomarker for BD.”
BackgroundThe Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar Depression
McGuffin, P., Rijsdijk, F., Andrew, M., Sham, P., Katz, R., & Cardno, A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.5.497 · Cited by 1,243
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Mayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166
A cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
BDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958
Geddes, J. R., & Miklowitz, D. J. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60857-0 · Cited by 848
Blood BDNF Concentrations Reflect Brain-Tissue BDNF Levels across Species
Klein, A. B., Williamson, R., Santini, M. A., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G. M., & Aznar, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000738 · Cited by 726
Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1243 · Cited by 721
Monroe, S. M., & Harkness, K. L. (2005) · Psychological Review · doi:10.1037/0033-295x.112.2.417 · Cited by 693
Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639 · cited 1×
“Activation of microglia may mediate neuronal and glial cell injury and death through activation of pro-inflammatory factors, such as cytokines, chemokines, metalloproteinases, cytotoxic factors, or complement system proteins.(4,144,145) Upon activation, microglia can produce pro-inflammatory (at M1 polarization) or an…”
BackgroundThe role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594
Meyer, J. H., Ginovart, N., Boovariwala, A., Sagrati, S., Hussey, D., Garcia, A., Young, T., Praschak-Rieder, N., Wilson, A. A., & Houle, S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1209 · Cited by 585
Cytokines and schizophrenia: microglia hypothesis of schizophrenia
Monji, A., Kato, T., & Kanba, S. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01945.x · Cited by 508 · cited 1×
“neuroinflammation is accepted as a pathogenic factor in these diseases).(125,126) The exchange of signals between neurons and the glial cells at the CNS level is achieved by means of chemokines, cytokines and the complement system.”
BackgroundBipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
Savitz, J., & Drevets, W. C. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.01.004 · Cited by 494
Polyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., & Schroeter, M. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.044 · Cited by 488 · cited 2×
“A systematic review and meta-analysis confirmed that peripheral BDNF levels in BD are consistently reduced during manic and depressive episodes and plasma levels of BDNF are recovered after treatment for acute mania, that is, the BDNF plasma or serum levels are not different in euthymia when compared to controls.(73,7…”
ResultLener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A. C., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.005 · Cited by 468 · cited 2×
“Drugs acting through glutamate signaling pathways, such as ketamine, could be used for treatment of the depressive episode.(55) Currently, several new drugs exploring the glutamate pathway are in development.”
BackgroundLucas, K., & Maes, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8425-7 · Cited by 466
Perry, D. C., Sturm, V. E., Peterson, M. J., Pieper, C. F., Bullock, T., Boeve, B. F., Miller, B. L., Guskiewicz, K. M., Berger, M. S., Kramer, J. H., et al. (2016) · Journal of Neurosurgery · doi:10.3171/2015.2.jns14503 · Cited by 440
The promise of N-acetylcysteine in neuropsychiatry
Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434 · cited 1×
“NAC is a promising novel therapeutic option for BD and other neuropsychiatric disorders, because NAC targets glutamatergic transmission, glutathione, neurotrophins, apoptosis, mitochondrial function, and inflammatory pathways.(238) Recent studies have provided data about the positive effects of chronic treatment by mo…”
BackgroundRao, J. S., Harry, G. J., Rapoport, S. I., & Kim, H. W. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.47 · Cited by 432 · cited 1×
“Post-mortem studies have shown that BD patients present increased pro-inflammatory and decreased anti-inflammatory markers in the frontal cortex.(133,134) Recently, BD has been discussed to be characterized by glial pathology and neuroinflammation.”
BackgroundToward constructing an endophenotype strategy for bipolar disorders
Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Clay, H. B., Daws, S., & Konradi, C. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.08.007 · Cited by 399 · cited 2×
“Mitochondrial dysfunctions in BD include: (i) decreased mitochondrial respiration due to reduced activity of mitochondrial complexes in electron transport system; (ii) changes in mitochondrial morphology; (iii) increases in mtDNA polymorphisms, deletions or mutations; and (iv) decreased levels of high-energy phosphate…”
BackgroundFernandes, B. S., Gama, C. S., Maria Ceresér, K., Yatham, L. N., Fries, G. R., Colpo, G., de Lucena, D., Kunz, M., Gomes, F. A., & Kapczinski, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.002 · Cited by 389
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375
Miura, T., Noma, H., Furukawa, T. A., Mitsuyasu, H., Tanaka, S., Stockton, S., Salanti, G., Motomura, K., Shimano-Katsuki, S., Leucht, S., et al. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70314-1 · Cited by 364 · cited 1×
“In view of the efficacy in prevention of both manic and depressive episodes relapse and recurrence, lithium was recommended in the firstline treatment in patients with BD.(232,233) New putative treatment of BD should be based on drug-induced modulation of multiple intracellular targets included in pathophysiology of B…”
BackgroundSynaptic plasticity and mood disorders
Duman, R. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001016 · Cited by 363
Beumer, W., Gibney, S. M., Drexhage, R. C., Pont-Lezica, L., Doorduin, J., Klein, H. C., Steiner, J., Connor, T. J., Harkin, A., Versnel, M. A., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212100 · Cited by 347 · cited 1×
“The macrophage/T-cell hypothesis of depression states that chronically activated macrophages and T-cells in periphery and microglia in the brain produce inflammatory cytokines, which modify brain functions and, in conjunction with genetic and environmental factors, precipitate the symptoms of BD.(167) The hypothesis o…”
BackgroundCytokines and Glucocorticoid Receptor Signaling
Pace, T. W. W., & Miller, A. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04984.x · Cited by 339
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Self-citationNery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298
Fernandes, B. S., Molendijk, M. L., Köhler, C. A., Soares, J. C., Leite, C. M. G. S., Machado-Vieira, R., Ribeiro, T. L., Silva, J. C., Sales, P. M. G., Quevedo, J., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0529-7 · Cited by 291 · cited 2×
“A systematic review and meta-analysis confirmed that peripheral BDNF levels in BD are consistently reduced during manic and depressive episodes and plasma levels of BDNF are recovered after treatment for acute mania, that is, the BDNF plasma or serum levels are not different in euthymia when compared to controls.(73,7…”
BackgroundResultAutoimmune diseases, bipolar disorder, and non-affective psychosis
Eaton, W. W., Pedersen, M. G., Nielsen, P. R., & Mortensen, P. B. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00853.x · Cited by 262
Hypothalamic-pituitary-adrenal axis and bipolar disorder
Daban, C., Vieta, E., Mackin, P., & Young, A. H. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.01.005 · Cited by 245
Frey, B. N., Andreazza, A. C., Houenou, J., Jamain, S., Goldstein, B. I., Frye, M. A., Leboyer, M., Berk, M., Malhi, G. S., Lopez-Jaramillo, C., et al. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413478217 · Cited by 234
Identification of Pathways for Bipolar Disorder: A Meta-analysis
Nurnberger, J. I., Koller, D. L., Jung, J., Edenberg, H. J., Foroud, T., Guella, I., Vawter, M. P., & Kelsoe, J. R. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.176 · Cited by 234
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
Gigante, A. D., Bond, D. J., Lafer, B., Lam, R. W., Young, L. T., & Yatham, L. N. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01033.x · Cited by 226
Review of the Literature on Major Mental Disorders in Adult Patients With Mitochondrial Diseases
Fattal, O., Budur, K., Vaughan, A. J., & Franco, K. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.1.1 · Cited by 209
Kunugi, H., Hori, H., Adachi, N., & Numakawa, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02135.x · Cited by 200
Rosenblat, J. D., Kakar, R., Berk, M., Kessing, L. V., Vinberg, M., Baune, B. T., Mansur, R. B., Brietzke, E., Goldstein, B. I., & McIntyre, R. S. (2016) · Bipolar Disorders · doi:10.1111/bdi.12373 · Cited by 199 · cited 2×
“A meta-analysis confirmed a moderate antidepressant effect for various adjunctive anti-inflammatory agents compared with conventional therapy alone in the treatment of BD.(251) Efficiency of antipsychotics in BD treatment emphasizes the role of regulation of the dopamine system; however, the intrinsic anti-inflammator…”
BackgroundResultIs impaired neurogenesis relevant to the affective symptoms of depression?
Sapolsky, R. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.012 · Cited by 188
Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Muneer, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.18 · Cited by 187
Meyer, J. H., Wilson, A. A., Sagrati, S., Miler, L., Rusjan, P., Bloomfield, P. M., Clark, M., Sacher, J., Voineskos, A. N., & Houle, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.156 · Cited by 182
Oxidative stress in early stage Bipolar Disorder and the association with response to lithium
de Sousa, R. T., Zarate, C. A., Zanetti, M. V., Costa, A. C., Talib, L. L., Gattaz, W. F., & Machado-Vieira, R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.11.011 · Cited by 169 · cited 1×
“Patients with BD treated with lithium have reduced lipid peroxidation (TBARS), which indicates antioxidant effects of lithium in the prevention of BD progression and clinical efficiency.(234,235) Antioxidants, such as N-acetylcysteine (NAC) seem to be beneficial in treatment of both major depressive episodes(236) and…”
BackgroundStage managing bipolar disorder
Berk, M., Berk, L., Dodd, S., Cotton, S., Macneil, C., Daglas, R., Conus, P., Bechdolf, A., Moylan, S., & Malhi, G. S. (2014) · Bipolar Disorders · doi:10.1111/bdi.12099 · Cited by 163 · cited 3×
“Insights into the processes underlying neuroprogression in BD have been provided by studies examining genetic and epigenetic changes, structural and functional changes in the brain, damage in neuronal circuits, disturbed circadian rhythms, changes in immune and endocrine systems, impairment in neuronal plasticity and…”
BackgroundRay, M. T., Shannon Weickert, C., & Webster, M. J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.26 · Cited by 161
Signaling mechanisms underlying dendrite formation
Miller, F. D., & Kaplan, D. R. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00072-2 · Cited by 160
Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression
Licznerski, P., & Duman, R. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.057 · Cited by 157
Role of neuro-immunological factors in the pathophysiology of mood disorders
Bhattacharya, A., Derecki, N. C., Lovenberg, T. W., & Drevets, W. C. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4214-0 · Cited by 149
Anand, A., Barkay, G., Dzemidzic, M., Albrecht, D., Karne, H., Zheng, Q.-H., Hutchins, G. D., Normandin, M. D., & Yoder, K. K. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00936.x · Cited by 139
Harrisberger, F., Smieskova, R., Schmidt, A., Lenz, C., Walter, A., Wittfeld, K., Grabe, H. J., Lang, U. E., Fusar-Poli, P., & Borgwardt, S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.017 · Cited by 138
Yildiz, A., Nikodem, M., Vieta, E., Correll, C. U., & Baldessarini, R. J. (2015) · Psychological Medicine · doi:10.1017/s0033291714001305 · Cited by 128
The circadian system of patients with bipolar disorder differs in episodes of mania and depression
Nováková, M., Praško, J., Látalová, K., Sládek, M., & Sumová, A. (2015) · Bipolar Disorders · doi:10.1111/bdi.12270 · Cited by 123 · cited 1×
“The hypothesis that internal desynchronization and changes in melatonin rhythmicity participate in the genesis of BD has been discussed.(180,181) Disturbances of sleep timing are worse during mood episodes, but still apparent during euthymic periods.”
BackgroundTaylor, D. M., Cornelius, V., Smith, L., & Young, A. H. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12343 · Cited by 122
The functional neuroanatomy of bipolar disorder
Cerullo, M. A., Adler, C. M., Delbello, M. P., & Strakowski, S. M. (2009) · International Review of Psychiatry · doi:10.1080/09540260902962107 · Cited by 113 · cited 1×
“Altered brain activation was identified in various regions in the cortico-limbic pathways; the most consistent findings were overactivation of the amygdala, striatum, and thalamus.(19) All studies using fMRI in BD supported the cortico-limbic hypothesis and suggest that connectivity can be more complex and that intra-…”
BackgroundIncreased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
Barbosa, I. G., Huguet, R. B., Mendonça, V. A., Sousa, L. P., Neves, F. S., Bauer, M. E., & Teixeira, A. L. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0116-z · Cited by 108
T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.
Kim, Y.-K., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, S.-W., Leonard, B. E., & Steinbusch, H. W. M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.08.005 · Cited by 100
Hayashi, T. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12262 · Cited by 87
Investigating the mechanism(s) underlying switching between states in bipolar disorder
Young, J. W., & Dulcis, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.019 · Cited by 68
A preliminary investigation on the efficacy of N -acetyl cysteine for mania or hypomania
Vieira da Silva Magalhães, P., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413481631 · Cited by 58
Lee, H.-J., Son, G.-H., & Geum, D. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.3.225 · Cited by 48
Photoperiodic and circadian bifurcation theories of depression and mania
Kripke, D. F., Elliott, J. A., Welsh, D. K., & Youngstedt, S. D. (2015) · F1000Research · doi:10.12688/f1000research.6444.1 · Cited by 48
Payne, J. L., Quiroz, J. A., Zarate, C. A., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01676-1 · Cited by 46 · cited 2×
“In conclusion, it appears that polymorphisms in the CLOCK gene, along with sleep disruption and resulting increase of CREB, BDNF, and TrkB, might be decisive factors in the induction of the switch to manic/hypomanic episode in BD patients.(278,287) We suppose that disturbed activities of signaling pathways regulated b…”
BackgroundBeyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
Data-Franco, J., Singh, A., Popovic, D., Ashton, M., Berk, M., Vieta, E., Figueira, M. L., & Dean, O. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.004 · Cited by 38
Research works printed but not linked: 209
- 10.3389/fpsyt.2014.00048 · DOI · Paper page
- 10.1007/s11920-014-0541-1 · DOI
- 10.1017/S1461145713000096 · DOI
- Duong A, 2015, Biomarkers for bipolar disorder: Current insights, Curr. Biomark. Find., 5, 79
- 10.1007/s11920-014-0514-4 · DOI
- 10.1176/appi.ajp.159.11.1841 · DOI · Paper page
- 10.1016/j.biopsych.2007.03.005 · DOI · Paper page
- 10.1016/S0006-3223(02)01350-1 · DOI · Paper page
- 10.1001/archpsyc.65.9.1017 · DOI · Paper page
- 10.1016/j.biopsych.2010.01.020 · DOI · Paper page
- 10.1038/mp.2015.227 · DOI · Paper page
- 10.3389/fpsyt.2014.00098 · DOI · Paper page
- 10.1016/j.jad.2013.05.083 · DOI · Paper page
- 10.2147/TACG.S39297 · DOI
- 10.1038/nrg2381 · DOI · Paper page
- 10.1111/j.1440-1819.2007.01604.x · DOI · Paper page
- 10.3109/01612840.2010.541588 · DOI
- 10.2147/NDT.S28117 · DOI
- 10.1177/070674370705201203 · DOI
- 10.1186/1471-244X-13-213 · DOI
- 10.1016/j.jpsychires.2014.09.014 · DOI · Paper page
- 10.1111/pcn.12247 · DOI
- 10.1016/S0140-6736(13)60855-7 · DOI · Paper page
- 10.1016/j.conb.2015.07.002 · DOI
- 10.1093/hmg/ddw181 · DOI · Paper page
- 10.1007/978-1-4614-7940-6_6 · DOI
- 10.1176/ajp.122.5.509 · DOI · Paper page
- 10.1055/s-2007-979535 · DOI · Paper page
- 10.1503/cmaj.080697 · DOI · Paper page
- 10.1016/j.pnpbp.2013.04.009 · DOI · Paper page
- 10.1037/a0038550 · DOI · Paper page
- 10.1016/j.pnpbp.2016.02.012 · DOI
- 10.1034/j.1399-5618.2001.30604.x · DOI
- 10.1038/mp.2008.29 · DOI · Paper page
- 10.1002/ajmg.b.30829 · DOI
- 10.1007/s00213-009-1660-y · DOI
- 10.1111/j.1600-0447.2007.01058.x · DOI · Paper page
- 10.1016/j.jad.2011.08.017 · DOI
- 10.1001/archpsyc.63.7.741 · DOI
- 10.1038/mp.2010.24 · DOI
- 10.1038/sj.mp.4002130 · DOI · Paper page
- 10.1038/nrd2462 · DOI · Paper page
- 10.5607/en.2014.23.1.28 · DOI
- 10.1016/j.drudis.2016.01.016 · DOI · Paper page
- 10.1016/j.pneurobio.2015.12.001 · DOI
- 10.1046/j.1471-4159.2003.01925.x · DOI · Paper page
- 10.2174/187152708783885174 · DOI · Paper page
- Fišar Z, 2010, Intracellular signalling pathways and mood disorders, Folia Biol. (Praha), 56, 135, 10.14712/fb2010056040135 · DOI
- 10.1111/j.1471-4159.2006.03980.x · DOI
- 10.1007/978-3-642-45106-5_3 · DOI
- 10.1016/j.biopsych.2005.11.004 · DOI
- 10.1016/j.pnpbp.2014.08.013 · DOI
- 10.1016/j.nbd.2009.11.010 · DOI · Paper page
- 10.1038/mp.2013.172 · DOI · Paper page
- 10.1016/j.neulet.2009.09.044 · DOI
- 10.1016/j.jpsychires.2009.04.010 · DOI
- 10.4306/pi.2010.7.4.243 · DOI · Paper page
- 10.1177/0269881115578161 · DOI
- 10.1016/j.neulet.2009.01.028 · DOI
- 10.1503/jpn.100048 · DOI · Paper page
- 10.1111/j.1440-1819.2010.02113.x · DOI · Paper page
- 10.1016/j.pnpbp.2013.12.001 · DOI · Paper page
- 10.3109/07853890.2015.1131327 · DOI · Paper page
- 10.1021/cn5000277 · DOI
- 10.1038/npp.2008.107 · DOI
- 10.1186/s12888-014-0366-9 · DOI
- 10.1016/j.pnpbp.2014.01.012 · DOI
- 10.3109/15622975.2010.518629 · DOI
- 10.1016/j.jad.2013.07.041 · DOI
- 10.1016/j.jpsychires.2009.11.020 · DOI
- 10.1016/j.jpsychires.2008.10.005 · DOI
- 10.1002/hup.2271 · DOI
- 10.1016/j.jad.2010.03.003 · DOI
- 10.1002/ajmg.b.31153 · DOI
- 10.1016/j.pnpbp.2013.01.008 · DOI
- 10.1016/j.phrs.2013.04.004 · DOI
- 10.1007/s12031-015-0523-8 · DOI
- 10.1016/j.jad.2011.07.021 · DOI
- 10.1016/j.pnpbp.2013.01.003 · DOI
- 10.1002/hup.1215 · DOI
- 10.1016/S0006-8993(97)01525-4 · DOI · Paper page
- 10.1016/S0304-3940(99)00083-X · DOI
- 10.1159/000054584 · DOI · Paper page
- 10.1124/dmd.109.028787 · DOI
- 10.1016/j.biopsych.2005.10.021 · DOI · Paper page
- 10.1007/s00018-012-1020-7 · DOI
- 10.1016/S1566-2772(02)00044-0 · DOI
- 10.2174/1389450110607011399 · DOI
- 10.1002/bies.20658 · DOI
- 10.2165/11530010-000000000-00000 · DOI · Paper page
- 10.1111/pcn.12299 · DOI
- 10.1093/ijnp/pyw012 · DOI
- 10.1016/j.psyneuen.2012.08.005 · DOI
- Kato TA, 2013, Neurotransmitters, psychotropic drugs and microglia: Clinical implications for psychiatry, Curr. Med. Chem., 20, 331
- 10.1155/2013/608654 · DOI · Paper page
- 10.1046/j.1471-4159.2001.00628.x · DOI
- 10.1111/cns.12390 · DOI
- Kunz M, 2011, Serum levels of IL‐6, IL‐10 and TNF‐α in patients with bipolar disorder and schizophrenia: Differences in pro‐ and anti‐inflammatory balance, Rev. Bras. Psiquiatr., 33, 268
- 10.1159/000356539 · DOI
- Patel JP, 2015, Disruption in the blood–brain barrier: The missing link between brain and body inflammation in bipolar disorder?, Neural Plast., 70, 830
- 10.1007/s13311-013-0207-4 · DOI
- 10.1016/j.jpsychires.2006.07.013 · DOI · Paper page
- 10.2174/13894501113149990014 · DOI
- 10.1016/j.jpsychires.2014.02.021 · DOI
- 10.1016/j.ejphar.2013.01.072 · DOI · Paper page
- 10.1007/s11920-013-0387-y · DOI
- 10.1017/S1461145708009310 · DOI · Paper page
- 10.1016/j.pnpbp.2007.02.018 · DOI
- 10.1111/acps.12451 · DOI
- 10.1111/j.1399-5618.2009.00757.x · DOI
- 10.1007/s00406-012-0327-6 · DOI
- 10.1016/j.biopsych.2013.01.007 · DOI · Paper page
- 10.1016/j.psyneuen.2014.07.013 · DOI · Paper page
- 10.1016/j.psyneuen.2015.10.014 · DOI · Paper page
- 10.1007/s12017-009-8072-3 · DOI
- 10.1016/j.jad.2012.07.019 · DOI
- 10.1016/j.jad.2015.05.065 · DOI
- 10.1016/j.bbi.2014.06.200 · DOI
- 10.3389/fncel.2015.00258 · DOI
- 10.1016/j.pnpbp.2010.12.017 · DOI · Paper page
- 10.1016/j.brainres.2005.12.056 · DOI · Paper page
- 10.1016/j.neuint.2008.01.013 · DOI
- 10.1016/j.neubiorev.2014.05.007 · DOI · Paper page
- 10.1111/j.1399-5618.2006.00359.x · DOI
- 10.1081/CBI-100103961 · DOI
- 10.1001/archpsyc.57.6.572 · DOI · Paper page
- Pohanka M, 2013, Impact of melatonin on immunity: A review, Cent. Eur. J. Med., 8, 369
- 10.1080/15622970600571822 · DOI · Paper page
- 10.1111/bdi.12286 · DOI
- 10.1023/A:1015187601628 · DOI · Paper page
- 10.1007/s11920-014-0483-7 · DOI · Paper page
- 10.3109/07420528.2015.1062024 · DOI
- 10.1016/j.cub.2008.04.012 · DOI · Paper page
- 10.1128/MCB.01047-09 · DOI
- 10.3389/fpsyt.2015.00118 · DOI
- 10.1016/j.pnpbp.2010.05.004 · DOI · Paper page
- 10.1111/jnc.12316 · DOI
- 10.1038/mp.2012.188 · DOI
- 10.1016/j.psychres.2014.04.005 · DOI · Paper page
- 10.1590/S1516-44462008000300011 · DOI
- 10.1016/j.ejphar.2015.07.013 · DOI
- 10.1080/07853890801923753 · DOI · Paper page
- Jou S‐H, 2009, Mitochondrial dysfunction and psychiatric disorders, Chang Gung Med. J., 32, 370
- Hroudová J, 2014, Mitochondrial dysfunctions in neurodegenerative diseases: Relevance to Alzheimer's disease, Biomed. Res. Int., 17, 50
- 10.1590/1516-4446-2013-1224 · DOI
- Toker L, 2015, Mitochondrial dysfunction in psychiatric morbidity: Current evidence and therapeutic prospects, Neuropsychiatr. Dis. Treat., 11, 2441
- 10.1517/14728222.2014.940893 · DOI
- 10.1007/s11011-008-9118-1 · DOI · Paper page
- Kim HK, 2015, The potential role of the NLRP3 inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder, Neural Plast., 40, 813
- 10.1038/sj.mp.4001711 · DOI · Paper page
- 10.1016/j.pnpbp.2006.03.012 · DOI · Paper page
- 10.1016/j.pscychresns.2012.02.003 · DOI · Paper page
- 10.1016/j.pnpbp.2012.11.007 · DOI
- 10.1038/sj.npp.1301671 · DOI · Paper page
- 10.1016/j.toxlet.2012.07.017 · DOI
- 10.1177/0004867412449303 · DOI
- 10.2174/1389557515666150324122026 · DOI
- 10.1016/j.pnpbp.2016.01.008 · DOI
- Nicholls DG, 1787, Mitochondrial calcium function and dysfunction in the central nervous system, Biochim. Biophys. Acta, 2009, 1416
- Fišar Z, 2016, Effect of simvastatin, coenzyme Q10, resveratrol, acetylcysteine and acetylcarnitine on mitochondrial respiration, Folia Biol. (Praha), 62, 53, 10.14712/fb2016062020053 · DOI
- 10.1034/j.1399-5618.2000.020305.x · DOI · Paper page
- 10.2165/00023210-200721010-00001 · DOI
- 10.1016/j.ceca.2007.11.005 · DOI
- 10.1016/j.pharmthera.2014.10.002 · DOI · Paper page
- 10.1016/S0140-6736(11)60873-8 · DOI · Paper page
- 10.1038/npp.2010.192 · DOI · Paper page
- 10.1097/JCP.0b013e3181f15849 · DOI
- 10.1111/j.1600-0447.2012.01889.x · DOI
- Khairova R, 2012, Effects of lithium on oxidative stress parameters in healthy subjects, Mol. Med. Rep., 5, 680
- 10.1590/S1516-44462011000400011 · DOI
- 10.1111/j.1440-1819.2010.02178.x · DOI
- 10.1111/j.1399-5618.2009.00729.x · DOI
- 10.1017/S1461145708009802 · DOI · Paper page
- 10.1016/S0163-7258(02)00299-1 · DOI · Paper page
- 10.1038/sj.npp.1300731 · DOI · Paper page
- 10.1159/000314310 · DOI · Paper page
- 10.1097/HRP.0000000000000006 · DOI
- 10.1186/s12974-014-0140-4 · DOI
- 10.1155/2009/705379 · DOI
- 10.1186/1741-7015-11-74 · DOI · Paper page
- 10.1136/bmjopen-2011-000643 · DOI
- 10.3389/fnins.2015.00372 · DOI · Paper page
- 10.2174/138955711795906941 · DOI
- 10.1016/j.schres.2013.09.011 · DOI
- 10.1016/j.ejphar.2015.08.046 · DOI
- 10.3389/fncel.2014.00370 · DOI
- 10.1016/j.jad.2013.12.008 · DOI
- 10.1111/pcn.12386 · DOI
- 10.1177/070674371405901208 · DOI
- 10.1016/j.jad.2007.03.007 · DOI
- 10.1586/ern.09.31 · DOI · Paper page
- 10.9758/cpn.2016.14.2.117 · DOI
- 10.1177/026988118700100104 · DOI
- 10.1176/appi.ajp.163.2.232 · DOI · Paper page
- 10.4088/JCP.v69n1009 · DOI
- 10.1016/j.jad.2009.02.007 · DOI
- 10.1016/j.neubiorev.2007.10.005 · DOI · Paper page
- 10.1097/HRP.0000000000000012 · DOI
- 10.1016/j.physbeh.2011.10.029 · DOI
- 10.1016/j.neubiorev.2007.04.003 · DOI · Paper page
200 of 209 shown
Cited by
Epidemiology and risk factors for bipolar disorder
Rowland, T. A., & Marwaha, S. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318769235 · Cited by 503
Hikikomori : Multidimensional understanding, assessment, and future international perspectives
Kato, T. A., Kanba, S., & Teo, A. R. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12895 · Cited by 335
Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis
Mazza, M. G., Lucchi, S., Tringali, A. G. M., Rossetti, A., Botti, E. R., & Clerici, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.012 · Cited by 326
Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182
“…of literature suggests that several pathophysiological processes may sequentially and/or concurrently occur in BD, as well as corticolimbic control circuits deterioration, monoaminergic neurotransmission imbalance or microglia homeostasis disruption (for review, see Sigitova et al., 2016 [154]).”
BackgroundToward Precision Psychiatry in Bipolar Disorder: Staging 2.0
Salagre, E., Dodd, S., Aedo, A., Rosa, A., Amoretti, S., Pinzon, J., Reinares, M., Berk, M., Kapczinski, F. P., Vieta, E., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00641 · Cited by 106
Metadata
- Authors
- Sigitova, E., Fišar, Z., Hroudová, J., Cikánková, T., & Raboch, J.
- Venue
- Psychiatry and Clinical Neurosciences
- Publisher
- Wiley
- Published
- 2017-01-06
- Volume
- 71
- Issue
- 2
- Pages
- 77-103
- ISSN
- 1323-1316 (ISSN-L)
- 1440-1819
- OpenAlex
- W2553608151
- Cited by
- 235
- References
- 79
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- Ministerstvo Zdravotnictví Ceské Republiky (15‐28616A)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.